长链非编码RNA SNHG3在恶性肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2021.01.010

Abstract

Abstract: Long non-coding RNA(lncRNA)is a kind of RNA molecule whose sequence length is more than 200 nucleotides and cannot encode a protein.In recent years,more and more studies have pointed out that lncRNA is closely related to the diagnosis,prevention,treatment and prognosis of tumors,and has great value in the clinical application of malignant tumors.Small nucleolar RNA host gene-3(SNHG3)plays a carcinogenic role in promoting cell proliferation,invasion and regulating epithelial-mesenchymal transition(EMT),suggesting that SNHG3 can be used as a biomarker to evaluate the malignancy of tumors.This article reviews the research progress of the relationship between SNHG3 and malignant tumors in recent years,and discusses the current situation and prospects of SNHG3 in the treatment of malignant tumor.

Key words: Small nucleolar RNA host gene-3, Long non-coding RNA, Malignant tumor

CLC Number:

R73-3

ZHENG Zhiyuan,QU Guofan. Research progress of long non-coding RNA SNHG3 in malignant tumor[J]. Journal of Practical Oncology, 2021, 35(1): 50-54.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2021.01.010

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2021/V35/I1/50

References

1 Rigoutsos I,Lee SK,Nam SY,et al.N-BLR,a primate-specific non-coding transcript leads to colorectal cancer invasion and migration[J].Genome Biol,2017,18(1):98.
2 Smolle MA,Pichler M.The role of Long Non-Coding RNAs in osteosarcoma[J].Noncoding RNA,2018,4(1):7.
3 Salmena L,Poliseno L,Tay Y,et al.A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language?[J].Cell,2011,146(3):353-358.
4 Liu L,Ni JJ,He XH.Upregulation of the long noncoding RNA SNHG3 promotes lung adenocarcinoma proliferation[J].Dis Markers,2018,2018:5736716.
5 Zhang T,Cao CH,Wu DH,et al.SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma[J].Tumour Biol,2016,37(2):2379-2385.
6 Zhang PF,Wang F,Wu J,et al.lncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma[J].J Cell Physiol,2019,234(3):2788-2794.
7 Ke AW,Shi GM,Zhou J,et al.CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells[J].Gastroenterology,2011,140(5):1629-1641.
8 Zhang PF,Li KS,Shen YH,et al.Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling[J].Cell Death Dis,2016,7(4):e2201.
9 Wu J,Liu LY,Jin HL,et al.LncSNHG3/miR-139-5p/BMI1 axis regulates proliferation,migration,and invasion in hepatocellular carcinom[J].Onco Targets Ther,2019,12:6623-6638.
10 Zhao Q,Wu CS,Wang JW,et al.lncRNA SNHG3 promotes hepatocellular tumorigenesis by targeting miR-326[J].Tohoku J Exp Med,2019,249(1):43-56.
11 Shi JD,Li JN,Yang S,et al.LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway[J].J Cell Physiol,2020,235(3):2891-2900.
12 Shi JD,Feng JJ,Xie J,et al.Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts[J].Sci Rep,2017,7(1):8660.
13 Xuan Y,Wang YN.Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation[J].Cell Death Dis,2019,10(10):694.
14 Huang WZ,Tian YM,Dong ST,et al.The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer[J].Oncol Rep,2017,38(3):1402-1410.
15 Chen J,Wu ZY,Zhang Y.lncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma[J].Int J Immunopathol Pharmacol,2019,33:2058738418820743.
16 Zheng SN,Jiang F,Ge DW,et al.lncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma[J].Biomed Pharmacother,2019,112:108695.
17 Kauppi M,Simonsen A,Bremnes B,et al.The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking[J].J Cell Sci,2002,115(pt5):899-911.
18 Xu SP,Kong DJ,Chen QL,et al.Oncogenic long noncoding RNA landscape in breast cancer[J].Mol Cancer,2017,16(1):129.
19 Taherian-Esfahani Z,Taheri M,Dashti S,et al.Assessment of the expression pattern of mTOR-associated lncRNAs and their genomic variants in the patients with breast cancer[J].J Cell Physiol,2019,234(12):22044-22056.
20 Sarabi MM,Ghareghani P,Khademi F,et al.Oral contraceptive use may modulate global genomic DNA methylation and promoter methylation of APC1 and ESR1[J].Asian Pac J Cancer Prev,2017,18(9):2361-2366.
21 Chang L,Hu Z,Zhou ZY,et al.SNHG3 promotes proliferation and invasion by regulating the miR-101/ZEB1 axis in breast cancer[J].RSC Advances,2018,8(27):15229-15240.
22 Wu HT,Zhong HT,Li GW,et al.Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer[J].J Transl Med,2020,18(1):51.
23 Cho HJ,Oh N,Park JH,et al.ZEB1 collaborates with ELK3 to repress E-Cadherin expression in triple-negative breast cancer cells[J].Mol Cancer Res,2019,17(11):2257-2266.
24 Ma QH,Qi XQ,Lin XN,et al.lncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer[J].Hum Cell,2020,33(1):232-242.
25 Li Y,Zhao ZH,Liu W,et al.SNHG3 functions as miRNA sponge to promote breast cancer cells growth through the metabolic reprogramming[J].Appl Biochem Biotechnol,2020,191(3):1084-1099.
26 Hong L,Chen WS,Wu DC,et al.Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer[J].Cancer Biomark,2018,22(3):367-374.
27 Sun J,Yang XM,Zhang R,et al.GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer[J].Cancer Med,2017,6(4):834-844.
28 Yamamoto TM,McMellen A,Watson ZL,et al.Activation of Wnt signaling promotes olaparib resistant ovarian cancer[J].Mol Carcinog,2019,58(10):1770-1782.
29 Pan HB,Kim E,Rankin GO,et al.Theaflavin-3,3'-digallate inhibits ovarian cancer stem cells via suppressing Wnt/β-catenin signaling pathway[J].J Funct Foods,2018,50:1-7.
30 Tang MKS,Yue PYK,Ip PP,et al.Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface[J].Nat Commun,2018,9(1):2270.
31 Li N,Zhan XH,Zhan XQ.The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes[J].Gynecol Oncol,2018,150(2):343-354.
32 Tian DG,Wei XP,Zhu H,et al.LncRNA-SNHG3 is an independent prognostic biomarker of intrahepatic cholangiocarcinoma[J].Int J Clin Exp Pathol,2019,12(7):2706-2712.
33 Zhang C,Qu Y,Xiao HB,et al.LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating TOP2A[J].Exp Cell Res,2019,384(1):111595.
34 Liu Z,Tao H.Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma[J].J Cell Biochem,2020,121(3):2150-2158.
35 Sui GQ,Zhang BT,Fei D,et al.The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis[J].J Cell Physiol,2020,235(10):6615-6624.
36 Fei F,He YS,He S,et al.LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21[J].Biosci Rep,2018,38(5):20180420.
37 Wang L,Su K,Wu HH,et al.LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis[J].Life Sci,2019,232:116597.
38 Peng LQ,Zhang YZ,Xin HL.LncRNA SNHG3 facilitates acute myeloid leukemia cell growth via the regulation of miR-758-3p/SRGN axis[J].J Cell Biochem,2020,121(2):1023-1031.

[1]	YANG Siqi,SONG Qibin,LI Qingqing,YAO Yi. Research progress of targeted inhibition of FGFRs signal in the treatment of malignant tumors [J]. Journal of Practical Oncology, 2021, 35(1): 73-77.
[2]	WEN Hongmei, CHEN Yang, SHI Qingping, REN Siying, GAO Jiao, QIN Mingfang. Analysis of cancer incidence and mortality in Yunnan cancer registry,2016 [J]. Journal of Practical Oncology, 2020, 34(6): 485-490.
[3]	XIANG Zhisheng, MA Jingyu, ZHONG Wenling, CHEN Tiehui, LIN Yongtian, JIANG Huijuan, ZHOU Yan. Analysis of the incidence and mortality of malignant tumors in Fujian,2016 [J]. Journal of Practical Oncology, 2020, 34(6): 491-494.
[4]	LI Jianxin, SHEN Binjie, WANG Xuan. Research progress of community follow-up model for malignant tumors [J]. Journal of Practical Oncology, 2020, 34(6): 540-543.
[5]	SONG Jiayu, FENG Yue, WANG Zhao, ZHANG Yunyan. The latest research progress of the correlation between exosomes and gynecological malignant tumor [J]. Journal of Practical Oncology, 2020, 34(6): 571-575.
[6]	MIAO Pengcheng, KANG Yindong, LI Fudong, MENG Dongdong, WANG Dongxing, CHANG Dehui. Research progress of lncRNA SNHGs in the occurrence and development of prostate cancer [J]. Journal of Practical Oncology, 2020, 34(5): 446-450.
[7]	CHENG Yue, ZHANG Mingyan, ZHANG Wenbo, XU Hui. Research progress of lncRNAs as members of ceRNAs networks in lung cancer [J]. Journal of Practical Oncology, 2020, 34(5): 451-455.
[8]	HAN Renqiang, WU Ming, MIAO Weigang, LUO Pengfei, YU Hao, ZHOU Jinyi. Malignant tumor epidemiology in Jiangsu province,2016 [J]. Journal of Practical Oncology, 2020, 34(4): 291-297.
[9]	LIN Yuhua, NI Zhenhua, SUN Yipeng, BI Junjie, WANG Xiongbiao. Research progress on the relationship between SPDEF and malignant tumors [J]. Journal of Practical Oncology, 2020, 34(2): 185-188.
[10]	ZHAO Yunxia, NIU Bo. Effect of lncRNA NBAT1 on proliferation of breast cancer cells by regulating the molecular axis of miR-3664-5p/Caspase 9 [J]. Journal of Practical Oncology, 2020, 34(1): 24-29.
[11]	GUO Yongdong, JIN Jing, LI Limin, HE Yutong. Progress in differentiation of non-protein-encoding RNA(DANCR)in common malignant tumors [J]. Journal of Practical Oncology, 2020, 34(1): 69-73.
[12]	BAO Le, TANG Liping. Progress of the EphB6 receptor in malignant tumors [J]. Journal of Practical Oncology, 2020, 34(1): 83-87.
[13]	LIU Gengchun, SHEN Liangfang. Relationship between serum long-chain non-coding RNA MALAT1 and AFAP1-AS1,and clinicopathological features and prognosis of nasopharyngeal carcinoma [J]. Journal of Practical Oncology, 2019, 33(6): 513-518.
[14]	LI Yafei, ZHANG Xiao, WANG Xuefei, WENG Mingjiao, WANG Tianzhen. Effect of RNA-binding protein Lin28 on the development of malignant tumors and its molecular mechanism [J]. Journal of Practical Oncology, 2019, 33(5): 456-460.
[15]	CHEN Hongbo, YU Zengrong, DING Xiaofan, XIAO Lin. Progress of correlation between bone marrow dose-volume parameters and acute hematologic toxicity in pelvic malignant tumor [J]. Journal of Practical Oncology, 2019, 33(4): 361-366.

Research progress of long non-coding RNA SNHG3 in malignant tumor

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments